Shin Nippon Biomedical Laboratories, Ltd.
TSE:2395.T
Overview | Financials
Company Name | Shin Nippon Biomedical Laboratories, Ltd. |
Symbol | 2395.T |
Currency | JPY |
Price | 1,221 |
Market Cap | 50,832,587,751 |
Dividend Yield | 3.53% |
52-week-range | 970 - 1,996 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. |
Website | https://www.snbl.co.jp |
An error occurred while fetching data.
About Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD